Latest News from "The Pink Sheet" DAILY

Prescription Drug Spending Rose 5.2% To $246.3 Billion In 2009, CMS Estimates

The agency's latest projections on national health expenditures for health care products and services is published online in Health Affairs.   read more

 

Ironwood IPO Raises Plenty of Cash and Plenty of Questions for Biotech Investors

The much-anticipated debut of the constipation-drug developer hits $188 million, but a venture owner had to buy nearly half the issue.   read more

 

California Hangs On To Its Biotech Crown, But Other States Are Luring Some Jobs

Should I stay or should I go? A new survey suggests many top execs think manufacturing and R&D are better off out-of-state.   read more

 

Pfizer Lowers Targeted Revenues for 2012; Wall Street Remains Skeptical

Pfizer's touts growth plans in emerging markets as the pharma prepares for the onset of Lipitor generics.   read more

 

Sanofi Expands Consumer Health Reach In China With Minsheng VMS Joint Venture

The deal gives Sanofi direct access to China's "booming" OTC vitamins and supplements segment, which pulled in an estimated $8 billion in retail value sales in 2009 and is growing at a rate of 4 percent in local currency, Euromonitor analysts say.   read more

 

Obama To Dems: "We've Got To Finish The Job On Health Care"

President Obama tries to rally Senate Democrats to finish health care reform legislation.   read more

 

Auxillium's Xiaflex Clears FDA With REMS To Educate Doctors On Safe Injection Techniques

REMS does not restrict type of physician who can administer the collagenase enzyme, which will launch in March.   read more

 

GSK Hunts for Novelty By Paying 11m To Apeiron In A Respiratory Deal

The privately owned Austrian biotech attracts GSK to a Phase I ARDS biologic.   read more

 

"The Pink Sheet" DAILY - Daily, in-depth analysis of the key developments shaping the biopharma industry. Not a subscriber? To register for a free trial, click here